Back to Products
New
Weight Management
Retatrutide
Retatrutide is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This triple-agonist mechanism represents the most advanced approach to metabolic research, with studies demonstrating superior outcomes compared to single and dual-agonist peptides. Research indicates significant effects on appetite regulation, energy expenditure, and metabolic function.
≥99% Purity · COA Certified
د.إ 700.00
Select Size
Quantity
1
For research purposes only. Not intended for human consumption or veterinary use.
Research Benefits
- ›Triple receptor agonism (GLP-1/GIP/Glucagon)
- ›Superior metabolic research outcomes
- ›Enhanced energy expenditure studies
- ›Appetite regulation research
- ›Next-generation weight management studies
Usage Guidelines
For research purposes only.
Storage & Handling
Store at 2–8°C. Do not freeze. Protect from light.
Reviews
No reviews yet. Be the first!
Loading research studies...
